 In December 2002, Pfizer sold the Tetra aquaristic and pond business to the "Triton Fund", a private independent European investment fund.Investors in the Triton Fund include European insurances and banks as well as significant American institutions.The Triton Fund paid $238.5 million US for the Tetra business.